SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
| ESTRACOMB TTS PATCHES | | Cutaneous patch · Transdermal use | 4 Box | SAR 56.50 | Generic · Prescription | NOVARTIS | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
| ACTIVELLE | 02249405 | 0.5 MG; 1 MG | TABLET · ORAL | NOVO NORDISK CANADA INC |
| ACTIVELLE LD | 02309009 | 0.5 MG; 0.1 MG | TABLET · ORAL | NOVO NORDISK CANADA INC |
| ESTALIS 140/50 MCG | 02241835 | 140 MCG / 24 HOUR; 50 MCG / 24 HOUR | PATCH · TRANSDERMAL | SANDOZ CANADA INCORPORATED |
| ESTALIS 250/50 MCG | 02241837 | 250 MCG / 24 HOUR; 50 MCG / 24 HOUR | PATCH · TRANSDERMAL | SANDOZ CANADA INCORPORATED |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
| US NADAC | COMBIPATCH 0.05-0.14 MG PTCH | $31.83617 | per EA | 23 Sep 2026 |
| US NADAC | COMBIPATCH 0.05-0.25 MG PTCH | $31.7862 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Estradiol 1mg / Norethisterone acetate 500microgram tablets | £13.20 | 84 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Estradiol 2mg / Norethisterone acetate 1mg tablets | £17.02 | 84 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Estradiol 30micrograms/24hours / Norethisterone 95micrograms/24hours transdermal patches | £15.46 | 8 patch | 1 Oct 2026 |
| NHS Drug Tariff | Estradiol 30micrograms/24hours / Norethisterone 95micrograms/24hours transdermal patches | £44.27 | 24 patch | 1 Oct 2026 |
| NHS Drug Tariff | Estradiol 40micrograms/24hours / Norethisterone 130micrograms/24hours transdermal patches | £15.46 | 8 patch | 1 Oct 2026 |
| NHS Drug Tariff | Estradiol 40micrograms/24hours / Norethisterone 130micrograms/24hours transdermal patches | £44.27 | 24 patch | 1 Oct 2026 |
| NHS Drug Tariff | Estradiol 50micrograms/24hours / Norethisterone 170micrograms/24hours transdermal patches | £44.28 | 24 patch | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.